‘At the Limits’ has been leading medical education for over 25 years with events in multiple disease areas across the globe.

See all the upcoming events here:
https://eu.eventscloud.com/website/7176/

The full multimedia of selected presentations is available on Open Dialogue, med-ed hub from At the Limits. Featuring live webcasts, interviews, and presentations from a host of the world’s leading researchers, scientists and clinicians, the hub includes hundreds of hours of archive material alongside the newest and most recent content.

https://opendialogue.health/

Demystifying AI and embedding it into clinical practice - Dirk Smeets | AI in Healthcare
37:01
Demystifying AI and embedding it into clinical practice - Dirk Smeets | AI in Healthcare
Cardiology, Diabetes & Nephrology At the Limits 2023 | Available to view now
0:33
Cardiology, Diabetes & Nephrology At the Limits 2023 | Available to view now
Professor Theresa McDonagh
28:58
Professor Theresa McDonagh
Professor Peter Libby
25:34
Professor Peter Libby
Professor Carel le Roux
32:14
Professor Carel le Roux
Debate a new era in the management of type 2 diabetes & cardiorenal disease
28:18
Debate a new era in the management of type 2 diabetes & cardiorenal disease
Professor Aruna Pradhan
26:07
Professor Aruna Pradhan
Professor Jean Pierre Després
33:18
Professor Jean Pierre Després
Professor Peter Stenvinkel
33:58
Professor Peter Stenvinkel
Professor Melanie Davies
26:22
Professor Melanie Davies
Professor Richard Schilling
24:30
Professor Richard Schilling
Professor Stephanie Baldeweg
23:11
Professor Stephanie Baldeweg
Professor Alastair O’Brien
42:27
Professor Alastair O’Brien
Professor Simon Griffin
28:47
Professor Simon Griffin
Professor May Ng
30:32
Professor May Ng
Dr Lucy Mackillop
32:16
Dr Lucy Mackillop
Dr Ian Prenelle
27:46
Dr Ian Prenelle
Debate: Cognitive markers are more useful than biomarkers in MS monitoring
55:18
Debate: Cognitive markers are more useful than biomarkers in MS monitoring
Professor Basil Sharrack and Professor John Snowden - AHSCT and the management of MS
34:00
Professor Basil Sharrack and Professor John Snowden - AHSCT and the management of MS
Professor Sergio Baranzini - The genetic and other risk factors underlying MS
26:54
Professor Sergio Baranzini - The genetic and other risk factors underlying MS
Professor Klaus Schmierer - Pushing the envelope at both ends of the disease spectrum
30:16
Professor Klaus Schmierer - Pushing the envelope at both ends of the disease spectrum
Professor Jon Stone - Undiagnosing MS, including the accuracy of clinical diagnosis
26:49
Professor Jon Stone - Undiagnosing MS, including the accuracy of clinical diagnosis
Professor Jeremy Chataway - Octopus - inside the progressive MS mega-trial
38:30
Professor Jeremy Chataway - Octopus - inside the progressive MS mega-trial
Professor Dr Lars Alfredsson - MS at the Limits 2022 - aetiology session
20:52
Professor Dr Lars Alfredsson - MS at the Limits 2022 - aetiology session
Dr Veronique Miron - Glial interactions driving remyelination in MS
30:18
Dr Veronique Miron - Glial interactions driving remyelination in MS
Dr Ruth Dobson - How pregnant women with MS are treated in the UK
31:12
Dr Ruth Dobson - How pregnant women with MS are treated in the UK
Dr Martina Absinta - Using paramagnetic rim lesions in proof-of-concept clinical trials
33:04
Dr Martina Absinta - Using paramagnetic rim lesions in proof-of-concept clinical trials
Dr Maria Teresa Cencioni - B-cells in multiple sclerosis — from targeted depletion ...
19:26
Dr Maria Teresa Cencioni - B-cells in multiple sclerosis — from targeted depletion ...
Dr Emma Tallantyre - DMT management – where disease biology and treatment algorithms meet (or not!)
40:58
Dr Emma Tallantyre - DMT management – where disease biology and treatment algorithms meet (or not!)
Dr E Ann Yeh - Longer-term safety of B-cell therapies in MS
28:12
Dr E Ann Yeh - Longer-term safety of B-cell therapies in MS